Atlas Trials

Study of Pharmacokinetics and Safety of Apraglutide in Participants With Normal and Impaired Kidney Function.

Clinical trial NCT04699032 · COMPLETED

Trial details

NCT number
NCT04699032
Sponsor
VectivBio AG
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Chronic Kidney Disease
Start date
2020-12-08
Primary completion
2021-07-05
Enrollment
16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.